Midjourney Launches Full-Body Ultrasound Scanner, Plans Spa

Midjourney launched Midjourney Medical, a new division, and revealed the Midjourney Scanner, an ultrasound-based full-body imaging device the company calls "Ultrasonic CT," per Midjourney's product page. The company website states the system can produce a full-body scan in 60 seconds, operates with "no radiation, no powerful magnetic fields," and aims to deploy roughly 50,000 units worldwide over the next six years and use this fleet of sensors to do a billion full-body scans every month. Midjourney's announcement names a flagship consumer-facing site, the Midjourney Spa in San Francisco, slated to open at the end of 2027, and describes the center as having hot tubs, saunas, cold plunges and 10 scanners. The Verge and Bloomberg covered the unveiling; Bloomberg quoted CEO David Holz saying "No such device has ever been built until now," and The Verge reports a development partnership with Butterfly Network, noting the system uses 40 Butterfly Ultrasound-on-Chip(tm) imaging modules per system.

Reporting by Panabee, citing company filings, describes the Midjourney-Butterfly Network agreement as including a $15 million upfront payment, $10 million in annual licensing fees, up to $9 million in milestone payments, plus revenue sharing on shipped hardware. Editorial analysis - technical context: public reporting and social posts attributed a set of specific hardware and data claims to Midjourney's technical materials. Aggregated social coverage collected by Digg and Twitter threads relayed figures including 8,960 individual transducers in a ring array, claims of picometer-range motion resolution, and high data rates (examples cited: 17 GB/s processing, 40 GB of raw data per cross-sectional slice), but those technical numbers are reported from Midjourney's public posts and secondary aggregations and have not been independently validated by third-party testing in the articles reviewed. The Verge's reporting that the system incorporates Butterfly's ultrasound-on-chip modules is a concrete supplier-level claim; Butterfly's modules are established as ultrasound-on-chip components but do not by themselves validate the end-to-end performance figures Midjourney published.

Editorial analysis: if independently verified, a rapid, non-ionizing, high-throughput whole-body ultrasonic imaging system would reshape screening and throughput economics compared with MRI and CT, which are constrained by scan time, magnet costs, and ionizing radiation respectively. However, ultrasound historically faces limits in bone/air interface penetration, operator dependence, and tissue-contrast differences versus MRI; clinical validation, peer-reviewed comparison studies, and regulatory clearance are standard gates for diagnostic adoption. Public reporting to date does not include peer-reviewed clinical trials, regulatory filings, or published validation datasets that demonstrate parity with MRI across diagnostic use cases.

Editorial analysis: observers should track the following indicators to assess the device's claims and deployment prospects:

• •Regulatory filings and approvals (FDA/CE) or public clinical trial registrations and publications
• •Independent benchmarking against MRI/CT in peer-reviewed studies and radiology conferences
• •Details on data handling, privacy, and integration with medical records and PACS
• •Commercial terms: pricing, reimbursement pathways, and hospital/clinic partnerships
• •Manufacturing and supply agreements that substantiate the 50,000-unit deployment target